Gene Therapy Research Institution,Co.,Ltd.   Report issue

For profit Phase 2
Founded: Utsunomiya Japan (2014)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2015
NCT02418598
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

aav-haadc-2 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1